Multicenter Phase II Study with Weekly Bendamustine and Paclitaxel as First- or Later-Line Therapy in Patients with Metastatic Breast Cancer: RiTa II Trial
暂无分享,去创建一个
S. Loibl | V. Nekljudova | G. von Minckwitz | O. Tomé | L. Müller | G. Doering | W. Wiest | A. Grote‐Metke | Roberto Müller | A. Maisch